Novo Nordisk A/S Specifies FY 2013 Sales Growth Guidance, Confirms FY 2013 Operating Profit Guidance and Lowers FY 2013 Net Income Guidance

Wednesday, 1 May 2013 01:30am EDT 

Novo Nordisk A/S announced that for the fiscal year 2013, sales growth measured in local currencies is now expected to be between 9% and 11%, operating profit growth measured in local currencies is still expected to be around 10%, and net income is expected to amount to approximately DKK 900 million. Previously, the Company expected sales growth of between 8% and 11% and net income of approximately DKK 1,400 million. For the fiscal year 2012, the Company reported revenue of DKK 78,026.00 million and operating profit of DKK 29,474.00 million. 

Company Quote

-1.36 -2.96%
30 Jan 2015